Novel molecules as in vivo biological probes
Novel molecules as in vivo biological probes
批准号:
7477445
负责人:
THOMAS James WANDLESS
金额:
$3.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-01-01 至 2009-12-31
关键词:
AdoptionAffinityAnimal ModelAnimalsAppendixBindingBioavailableBiologicalBiological AssayBiological ModelsBiomedical ResearchCellsChimeric ProteinsCommunitiesComplementary DNACultured CellsDevelopmentDiagnosisEmbryoFinancial compensationGene SilencingGenesGoalsHumanKnock-in MouseKnock-outKnockout MiceLifeLigandsMammalian CellMethodologyMethodsModelingMusPharmaceutical PreparationsPhenotypePhysiologyPropertyProteinsResearchResearch PersonnelRoleScreening procedureSystemTacrolimus Binding ProteinsTechniquesTechnologyTertiary Protein StructureTherapeuticTimeTransgenic OrganismsWithdrawalbasedesigndesirefunctional restorationhomologous recombinationhuman diseaseimprovedin vivointerestmouse modelmulticatalytic endopeptidase complexmutantnovelnull mutationprotein degradationprotein functionsmall moleculetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary: The broad, long-term objective of this application is the development of a
general method to reversibly regulate the stability (and thus function) of any protein of interest using
synthetic, bioavailable small molecules. This application describes basic biomedical research that, if
successful, would enable widespread advances in the diagnosis and treatment of human disease by
facilitating fundamental biological studies as well as new animal models of human disease.
It is known that fusion of an unstable protein domain to a second protein creates a chimeric
protein that is unstable in cells and degraded by the proteasome. The goal of this application is to
create an unstable protein domain that is conditionally stabilized when bound to a high-affinity ligand.
For use in mice, the unstable domain would be fused to a protein of interest in the context of a knock-
in mouse, and the stabilizing ligand would be constitutively administered until such time as it was
desired to interrogate the role of the protein of interest. Withdrawal of the ligand would cause rapid
degradation of the protein of interest. Readministering the ligand would stabilize the chimeric protein
to normal levels. The specific aims of this application incorporate both rational design and diversity-
based screening techniques to identify mutants of the FKBP protein that are unstable in mammalian
cells but stable when bound to a cell-permeable, high-affinity ligand. New ligands that possess
desirable pharmacological properties will be developed, and this method will be validated using
several proteins of known scientific and therapeutic importance.
Relevance: The goal of this research is to develop a general new method to rapidly and
reversibly inactivate a specific protein in either cultured human cells or in mice. This methodology
would enable the development of many new models for human diseases (e.g., cultured cells or
knock-out mice), and these model systems are enormously helpful in the ongoing search for new and
improved drugs to treat human diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulated Protein Degradation
-
批准号:10650884
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2022
-
负责人:THOMAS James WANDLESS
-
依托单位:
Regulated Protein Degradation
-
批准号:10417637
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2022
-
负责人:THOMAS James WANDLESS
-
依托单位:
LTQ Orbitrap XL ETD Mass Spectrometer
-
批准号:7793440
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel Molecules as In Vivo Biological Probes
-
批准号:9330164
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel Molecules as In Vivo Biological Probes
-
批准号:8120281
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel Molecules as In Vivo Biological Probes
-
批准号:7983424
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel Molecules as In Vivo Biological Probes
-
批准号:8470176
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel Molecules as In Vivo Biological Probes
-
批准号:8267691
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel molecules as in vivo biological probes
-
批准号:7038441
-
项目类别:
-
资助金额:$25.86万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel molecules as in vivo biological probes
-
批准号:7164408
-
项目类别:
-
资助金额:$25.25万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel molecules as in vivo biological probes
-
批准号:7568958
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel molecules as in vivo biological probes
-
批准号:7337983
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel Molecules as In Vivo Biological Probes
-
批准号:8926449
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Novel Molecules as In Vivo Biological Probes
-
批准号:8814488
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2006
-
负责人:THOMAS James WANDLESS
-
依托单位:
Conditional Protein Targeting
-
批准号:6671853
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2003
-
负责人:THOMAS James WANDLESS
-
依托单位:
Conditional Protein Targeting
-
批准号:7314358
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2003
-
负责人:THOMAS James WANDLESS
-
依托单位:
Conditional Protein Targeting
-
批准号:7105458
-
项目类别:
-
资助金额:$32.56万
-
财政年份:2003
-
负责人:THOMAS James WANDLESS
-
依托单位:
Conditional Protein Targeting
-
批准号:7635711
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2003
-
负责人:THOMAS James WANDLESS
-
依托单位:
Conditional Protein Targeting
-
批准号:6923922
-
项目类别:
-
资助金额:$33.26万
-
财政年份:2003
-
负责人:THOMAS James WANDLESS
-
依托单位:
Conditional Protein Targeting
-
批准号:6779951
-
项目类别:
-
资助金额:$33.18万
-
财政年份:2003
-
负责人:THOMAS James WANDLESS
-
依托单位:
海外基金